Navigation Links
Pharsight Expands Strategic Consulting Services Team
Date:9/10/2007

sed on population PK/PD modeling of small molecules in the areas of analgesia and depression. Mr. Monteleone also served as a lecturer in the Department of Pharmacology at the University of Auckland in New Zealand, where he provided instruction on clinical pharmacokinetics concepts and modeling tools, including Pharsight's WinNonlin(R). Mr. Monteleone holds an M.S. in Toxicology from the University of Arizona and has completed coursework for his Ph.D. in Pharmacology and Clinical Pharmacology from the University of Auckland. Mr. Monteleone has authored or co-authored several original research articles in the area of clinical trial design and simulation-based design optimization.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.

Registered Trademarks and Trademarks

Pharsight(R) is a registered trademark of Pharsight Corporation. All other brand and product names are trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. WARF expands license agreement with Advanced Cell Technology
2. Verizon expands broadband service in Wisconsin
3. Bandwidth provider expands in Milwaukee
4. Wisconsins biodiesel network expands
5. Quad/Graphics expands reach in western states
6. University of South Florida expands GE Healthcare relationship
7. Metavante expands healthcare payments division
8. Fiserv expands services to health plan market
9. Bone Care expands patent protection of core drug offering
10. SBC and AT&T merger expands global reach for Wisconsin businesses
11. Expetec expands IT staff services in Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):MDC researchers identify a scaffold regulating protein disposal 2Scientists identify natural anti-cancer defenses 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 48 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 18 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 3Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 1Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 3Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 4Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 1Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 2Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 3